Tilray Brands, Inc. (TLRY) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TLRY crossed above the 20-day moving average, suggesting a short-term bullish trend.The 20-day simple moving average is a popular investing tool. Traders like this SMA because it offers a look back at a stock's price over a shorter period and helps smooth out price fluctuations. The 20-day can also show more trend reversal signals than longer-term moving avera ...

Tilray Brands, Inc. (TLRY) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TLRY crossed above the 200-day moving average, suggesting a long-term bullish trend.The 200-day simple moving average is a useful tool for traders and analysts, establishing market trends for stocks, commodities, indexes, and other financial instruments over the long term. The marker moves higher or lower along with longer-term price moves, and serves as a sup ...

Mr. Mavroudis is a professional portfolio manager specializing in institutional and private portfolios. He focuses on risk management, which is accompanied by in-depth financial market analysis (fundamental, macro and technical) to control the risk undertaken by the portfolios. He invests in all financial instruments globally (stocks, bonds, fx, commodities), restructuring investment portfolios based on prevailing conditions and the needs of each client-investor. Mr. Mavroudis has successfully navigated all ...

Key Takeaways TLRY rose 44.1% on Friday after reports that an executive order could reclassify marijuana under federal law.Tilray Brands rallied as the reclassification could ease banking limits, tax burdens and investment barriers.Before the surge, TLRY was down 36.6% YTD, highlighting how quickly sentiment shifts on reform signals.Shares of cannabis producer Tilray Brands, Inc. (TLRY) surged 44.1% on Friday, Dec. 12, 2025, on reports that President Donald Trump is expected to sign an executive order as ea ...

Cannabis stocks surged significantly on Dec. 12, 2025, thanks to reports of President Trump's plans to ease federal marijuana regulations by reclassifying it to Schedule III from a Schedule I. This news sparked gains across major players, boosting investor optimism despite no final policy confirmation.Amplify Seymour Cannabis ETF (CNBS)  rallied more than 54% on the day for its best day on record, as mentioned in CNBC.If reclassified, the move would allow cannabis companies to fall under different tax regul ...

A quiet news day didn't stop several high-volatility healthcare and cannabis stocks from posting sharp after-hours gains on Friday, with traders leaning into recent catalysts and technical momentum.Tilray Brands, Inc. (TLRY): +11.36% After HoursTilray jumped to $13.53, extending a volatile week following its one-for-ten reverse stock split, effective December 1. Shares had closed at $12.15, already up 44.13% on the day. While no fresh news hit on Friday, investors continued to digest the company's restruct ...

The cannabis business might soon be a lot more lucrative.Shares of Tilray Brands (TLRY +43.89%) surged 65% this past week, according to data provided by S&P Global Market Intelligence. Investors are hopeful that the Trump administration will move to lessen costly regulations on the beleaguered cannabis industry. A highly anticipated executive orderPresident Donald Trump is reportedly contemplating a reclassification of marijuana from a Schedule I drug to a Schedule III drug, according to The Washington Post ...

U.S.-listed cannabis stocks are back in focus as expectations build around a potential shift in federal marijuana policy. Markets have reacted positively to reports that President Donald Trump is considering directing regulators to reclassify cannabis from Schedule I to Schedule III under the Controlled Substances Act.While such a move would not legalize marijuana outright, it would mark the most significant federal reform in decades, easing regulatory pressure, reducing punitive taxes, and potentially attr ...

加拿大科技与人工智能相关股票表现 - Celestica Inc 股价受“AI怀疑论”影响 当日下跌12.92% 对指数拖累最大 [1] - 尽管最新季度利润超预期 芯片公司Broadcom股价仍重挫11.4% 加剧市场对AI热潮的担忧 [4] - 作为AI热潮的代表公司 Nvidia股价下跌3.3% Oracle股价继前一日暴跌后 周五再跌4.5% [5] - Oracle的业绩令市场“有些失望” 加剧了AI怀疑论者对估值过高和预期过热的担忧 [5] 加拿大和美国大麻股表现 - 有报道称美国总统特朗普计划放宽联邦大麻限制 加拿大大麻公司股价应声大涨 [1] - Tilray Brands Inc 股价上涨44.35% Canopy Growth Corp 股价上涨52.87% Aurora Cannabis Inc 股价上涨19.04% Organigram Global Inc 股价上涨16.81% [2] - 分析师认为 尽管这些股票从低基数大幅上涨 但美国更激进的合法化可能使该板块重获生机 尽管可能性仍较渺茫 [2] 主要市场指数与商品表现 - 加拿大S&P/TSX综合指数下跌133.34点 收于31,527.39点 [3] - 美国道琼斯工业平均指数下跌245.96点 收于48,458.05点 标普500指数下跌73.59点 收于6,827.41点 纳斯达克综合指数下跌398.69点 收于23,195.17点 [6] - 加元兑美元汇率报72.63美分 前一交易日为72.60美分 [6] - 1月原油期货合约下跌16美分 至每桶57.44美元 2月黄金期货合约上涨15.30美元 至每盎司4,328.30美元 [6] 加拿大经济数据前瞻 - 投资者关注加拿大统计局将于周一发布的11月通胀数据 [3] - 路透社调查显示 经济学家普遍预测11月总体通胀率为2.3% [3] - 该数据将为判断加拿大经济健康状况以及通胀在2.25%的政策利率下是否受控提供线索 [3]

行业政策预期 - 有报道称投资者寄希望于特朗普总统将推动大麻重新分类为危险性低得多的药物 这导致Tilray公司股票及其他大麻公司股价飙升 [1] 公司股价表现 - Tilray公司股票出现飙升 [1] - 其他大麻公司的股票也出现飙升 [1]